Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384626503> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W4384626503 endingPage "118" @default.
- W4384626503 startingPage "116" @default.
- W4384626503 abstract "The FDA has approved zavegepant nasal spray (Zavzpret – Pfizer) for acute treatment of migraine with or without aura in adults. Zavzpret is the first nasal spray formulation of a calcitonin gene-related peptide (CGRP) receptor antagonist (“gepant”) to become available in the US." @default.
- W4384626503 created "2023-07-19" @default.
- W4384626503 date "2023-07-24" @default.
- W4384626503 modified "2023-10-03" @default.
- W4384626503 title "Zavegepant (Zavzpret) for Acute Treatment of Migraine" @default.
- W4384626503 doi "https://doi.org/10.58347/tml.2023.1681c" @default.
- W4384626503 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37460143" @default.
- W4384626503 hasPublicationYear "2023" @default.
- W4384626503 type Work @default.
- W4384626503 citedByCount "0" @default.
- W4384626503 crossrefType "journal-article" @default.
- W4384626503 hasConcept C118303440 @default.
- W4384626503 hasConcept C126322002 @default.
- W4384626503 hasConcept C142724271 @default.
- W4384626503 hasConcept C163170386 @default.
- W4384626503 hasConcept C170493617 @default.
- W4384626503 hasConcept C204787440 @default.
- W4384626503 hasConcept C27081682 @default.
- W4384626503 hasConcept C2776885963 @default.
- W4384626503 hasConcept C2777350023 @default.
- W4384626503 hasConcept C2778122271 @default.
- W4384626503 hasConcept C2778541695 @default.
- W4384626503 hasConcept C2778871607 @default.
- W4384626503 hasConcept C2778938600 @default.
- W4384626503 hasConcept C2780973058 @default.
- W4384626503 hasConcept C3017807917 @default.
- W4384626503 hasConcept C42219234 @default.
- W4384626503 hasConcept C71924100 @default.
- W4384626503 hasConcept C85663871 @default.
- W4384626503 hasConcept C98274493 @default.
- W4384626503 hasConceptScore W4384626503C118303440 @default.
- W4384626503 hasConceptScore W4384626503C126322002 @default.
- W4384626503 hasConceptScore W4384626503C142724271 @default.
- W4384626503 hasConceptScore W4384626503C163170386 @default.
- W4384626503 hasConceptScore W4384626503C170493617 @default.
- W4384626503 hasConceptScore W4384626503C204787440 @default.
- W4384626503 hasConceptScore W4384626503C27081682 @default.
- W4384626503 hasConceptScore W4384626503C2776885963 @default.
- W4384626503 hasConceptScore W4384626503C2777350023 @default.
- W4384626503 hasConceptScore W4384626503C2778122271 @default.
- W4384626503 hasConceptScore W4384626503C2778541695 @default.
- W4384626503 hasConceptScore W4384626503C2778871607 @default.
- W4384626503 hasConceptScore W4384626503C2778938600 @default.
- W4384626503 hasConceptScore W4384626503C2780973058 @default.
- W4384626503 hasConceptScore W4384626503C3017807917 @default.
- W4384626503 hasConceptScore W4384626503C42219234 @default.
- W4384626503 hasConceptScore W4384626503C71924100 @default.
- W4384626503 hasConceptScore W4384626503C85663871 @default.
- W4384626503 hasConceptScore W4384626503C98274493 @default.
- W4384626503 hasIssue "1681" @default.
- W4384626503 hasLocation W43846265031 @default.
- W4384626503 hasLocation W43846265032 @default.
- W4384626503 hasOpenAccess W4384626503 @default.
- W4384626503 hasPrimaryLocation W43846265031 @default.
- W4384626503 hasRelatedWork W2006390069 @default.
- W4384626503 hasRelatedWork W2062414108 @default.
- W4384626503 hasRelatedWork W2104250000 @default.
- W4384626503 hasRelatedWork W2161792711 @default.
- W4384626503 hasRelatedWork W2398429995 @default.
- W4384626503 hasRelatedWork W2792256483 @default.
- W4384626503 hasRelatedWork W3126309578 @default.
- W4384626503 hasRelatedWork W4233209762 @default.
- W4384626503 hasRelatedWork W4360614882 @default.
- W4384626503 hasRelatedWork W4386516431 @default.
- W4384626503 hasVolume "65" @default.
- W4384626503 isParatext "false" @default.
- W4384626503 isRetracted "false" @default.
- W4384626503 workType "article" @default.